Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-14

Clinical Trial Update: Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.

View source ↗

Summary

A clinical trial update examining bortezomib as a first salvage therapy for multiple myeloma patients who were previously exposed to bortezomib as initial treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Velcade (bortezomib)

Snippet

Sponsor: IRCCS Centro di Riferimento Oncologico della Basilicata | Conditions: Multiple Myeloma | Status: UNKNOWN